Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...
PSA levels measured at age 60 predict a man’s lifetime risk of metastasis and death from prostate cancer (PCa), according to a study published online in the British Medical Journal. Hans Lilja, MD, ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...